PADCEV EJFV 20 mg/2mL
ENFORTUMAB VEDOTIN · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · SEAGEN INC.
PADCEV EJFV is a injection, powder, lyophilized, for solution containing enfortumab vedotin at 20 mg/2mL, taken intravenous. Manufactured by SEAGEN INC..
Key Facts
- Brand Name
- PADCEV EJFV
- Generic Name
- ENFORTUMAB VEDOTIN
- NDC Code (Product)
51144-020- Manufacturer
- SEAGEN INC.
- Strength
- 20 mg/2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761137
- Marketing Start
- 12/18/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is PADCEV EJFV used for?
PADCEV EJFV contains ENFORTUMAB VEDOTIN. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is PADCEV EJFV a controlled substance?
PADCEV EJFV is not classified as a controlled substance by the DEA.
What is the generic name for PADCEV EJFV?
The generic name for PADCEV EJFV is ENFORTUMAB VEDOTIN. There are no other listed brand versions of ENFORTUMAB VEDOTIN.
What is the NDC code for PADCEV EJFV 20 mg/2mL?
The NDC (National Drug Code) for PADCEV EJFV 20 mg/2mL is 51144-020, listed by SEAGEN INC..
Other PADCEV EJFV Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)